Summary & Overview
HCPCS P9032: Platelets, Irradiated, Each Unit
HCPCS Level II code P9032 designates a single unit of irradiated platelets used for transfusion. Irradiated platelet units are clinically important for patients at risk of transfusion-associated graft-versus-host disease, including immunocompromised and certain oncology patients. Nationally, accurate coding of irradiated blood products matters for clinical tracking, inventory management, and appropriate payer adjudication.
This summary covers major national payers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise description of the code's clinical role and typical settings of service, plus an overview of what a full publication will address: payer coverage patterns, reimbursement benchmarks, billing and documentation considerations, and clinical context for use of irradiated platelet units. The publication will also summarize common modifiers and coding relationships where available.
Intended for billing professionals, clinical transfusion services, and policy analysts, the material explains how P9032 fits within transfusion service lines and what to expect in payer interactions and claims processing. Data not available in the input will be indicated where relevant.
Billing Code Overview
HCPCS Level II code P9032 describes platelets, irradiated, each unit. The service represents provision of a single unit of irradiated platelet blood product intended for transfusion. The typical service type is blood product transfusion and the usual site of service is hospital inpatient or hospital outpatient transfusion services, including transfusion centers and blood banks that prepare and dispense irradiated platelet units.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult hospitalized for chemotherapy-induced thrombocytopenia who requires transfusion of irradiated platelets to reduce the risk of transfusion-associated graft-versus-host disease. The patient presents with platelet count <10,000–20,000/µL or active bleeding with thrombocytopenia and has a history of recent or planned hematopoietic stem cell transplant, malignancy with immunosuppression, or prior transfusion reaction requiring irradiation. The clinical workflow includes: ordering of P9032 by the attending physician or hematologist/oncologist; verification of indication and compatibility by the transfusion service; blood bank processing to irradiate platelet units and label each unit; bedside administration by nursing with patient identification, baseline vital signs, and transfusion monitoring; documentation of unit lot numbers, pre- and post-transfusion platelet counts, and any transfusion reactions. Typical sites of service are inpatient hospital units (medical oncology, hematology, bone marrow transplant wards), outpatient infusion centers, and ambulatory surgical centers when transfusion is required peri-procedurally.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier (default) | Use when no additional billing modifier is applicable to the platelet unit charge. |